Navigation Links
Oxford Finance Corporation Facilitates Entry for Reata Pharmaceuticals into Asian Markets
Date:5/17/2010

ALEXANDRIA, Va., May 17 /PRNewswire/ -- Oxford Finance Corporation (Oxford), a subsidiary of Sumitomo Corporation, today announced that its ongoing strategy to offer value beyond its core product, senior secured debt, has provided substantial growth opportunities for its portfolio company, Reata Pharmaceuticals (Reata). Oxford provided a $15 million senior loan facility to Reata in 2007 and participated in a recent $32 million Series F equity round.  Oxford also introduced Reata to another Sumitomo Corporation subsidiary, Summit Pharmaceuticals International (SPI), which identified licensing opportunities for Reata in Japan as part of Sumitomo's integrated service to Oxford's portfolio companies.

These strategic business relationships resulted in an agreement between Kyowa Hakko Kirin, a leading biopharmaceutical company in Japan, and Reata that provides Kyowa Hakko Kirin exclusive rights to develop and commercialize Reata's lead compound, bardoxolone methyl, in Japan and other selected Asian markets.  Under the terms of the agreement, Reata is eligible to receive up to $272 million in upfront and milestone payments, as well as escalating double-digit royalties.

"From the beginning of our business relationship in 2007, Reata has taken full advantage of the breadth of services Oxford offers its clients," said J. Alden Philbrick, president and chief executive officer of Oxford Finance Corporation.  "Access to Asian markets is a huge opportunity for Reata, and we congratulate them on their successful execution of their agreement."

"Our relationship with Oxfo
'/>"/>

SOURCE Oxford Finance Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma
2. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
3. P&M Corporate Finance and Robin Young Announce 2010 Spine Technology Summit
4. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
5. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
6. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
7. PhRMA Statement on Senate Finance Committee Vote
8. Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech/Pharma Finance and Accounting Forum in San Francisco
9. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
10. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
11. Curexo Technology Corporation Raises $13.2 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group has ... their competitive landscape map for the Chronic Kidney ... 90 international companies with drugs and devices currently ... and its sequelae. (Logo:  ... , hypertension - renal denervation , ...
(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) ... difficile infection using National health insurance claims and ... 2, 2011 at the 21st Annual Scientific ... (SHEA).   (Logo:   http://photos.prnewswire.com/prnh/20090413/LA97352LOGO )Poster Presentation ...
... March 27, 2011 /PRNewswire-Asia/ -- Guangzhou General Hospital of ... the first Chinese regional military and civilian ... (mHealth) system is now in full operation. This network ... and a Remote Electrocardiograph (ECG) Diagnostic Center run by ...
Cached Medicine Technology:Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality 2Chinese Army Established the First Chest Pain Rescue Network in China by Using IVT mHealth System 2
(Date:5/19/2013)... The muscles in the human body are ... of the biggest and most significant nervous systems in ... system comprises of peripheral nerves that reside outside of ... that the limbs and hands, as well as other ... damaged due to trauma or physical injury, their functionality ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... Christi, TX (PRWEB) May 19, 2013 ... security systems companies. Homeowners who are considering an ... and services of the nation's leading security system providers ... systems reviews the best DIY home security system ... Every year 6Webs.com reviews dozens of home security companies ...
(Date:5/19/2013)... 19, 2013 The report “Feed Additives ... & Forecasts up to 2017” published by MarketsandMarkets, defines ... analysis and forecasting of the global volume and revenue ... driving and restraining factors for the global market with ... challenges. The market is segmented and revenue is forecasted ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The Pradaxa ... Management Conference was recently convened for hundreds of ... litigation now underway in U.S. District Court, Southern District ... Court’s website on May 14th, the Conference addressed the ... also reported during the Conference that Defendants submitted a ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... to the British throne has extended his generosity and assistance ... dire need of measures to get back the lost splendour. ... Clarence House, his London residence, to launch an international campaign ... a chain of palaces and temples built by Nepal's Malla ...
... a B.C. youngster a bowel, liver, pancreas and stomach. Lori MacIver ... of her son. She said, "They were telling me to prepare ... ,Her son Gairett, 18, is now recovering following a high-risk, ... now has a new bowel, stomach, liver and pancreas, all from ...
... of American families has revealed that only half of drug- ... doing so often gives positive results to 82% of them. ... Gallup poll, the USA Today/HBO Family Drug Addiction poll revealed ... addicted to drugs or alcohol. ,The findings of the ...
... milestone in the mapping of the bovine genome, which will ... disease// control in cattle. This research is slated to benefit ... up on a sequence of 2.9 million DNA base pairs, ... in one pair, which can alter the productivity of the ...
... technique for pain relief has been developed at the ... a lot of promise// in alleviating extreme pain, during ... Neurolytic block, which is a concoction of anaesthetic and ... into the para vertebral space. This works by blocking ...
... virus has afflicted 487 children and has claimed the ... the state.,The disease has been recently named// as Acute ... family welfare ministry. ,Experts at the Sanjay ... of professor in Microbiology department, Dr TN Dhole, had ...
Cached Medicine News:Health News:A Princely Assistance to the Nepal Heritage 2Health News:Rare Transplant Gives B.C Youngster 4 New Organs 2Health News:Rare Transplant Gives B.C Youngster 4 New Organs 3Health News:Eastern UP hit by killer virus – Coxsacki 2
... The instrument includes the ... has increased illumination for ... illumination. The Copeland retinoscope ... handle, and extended battery ...
... stereopsis from 800 to 40 ... young as 2 years of ... from left to right., ,Randot ... Book #1: 200 & 100 ...
... EasyEye is the only handheld non-contact tonometer with ... is streamlined, quiet and now, with constant ... a gentle puff of air. You can prove ... on the patient's hand before you start. ...
... 2000 Phenytoin Assay is a ... use in the quantitative analysis ... or plasma. Kits are packaged ... Roche COBAS MIRA, COBAS MIRA ...
Medicine Products: